Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Progress in the Treatment of Adult Langerhans Cell Histiocytosis --Review].

Zhongguo shi yan xue ye xue za zhi - 1 Jun 2022

Tian Zi-Zhu, Cui Ya-Juan, Peng Hong-Ling

Abstract excerpt

Langerhans cell histiocytosis (LCH) is a rare proliferative disease dominated by the proliferation of Langerhans cells, which is inflammatory myeloid neoplasms. Its clinical manifestations are variable, occurring at any age and at any site, and it is rarer in adults than in children. The gold standard for diagnosis is histopathological biopsy. Due to the rarity of adult LCH and the heterogeneity of this disease,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Child
Share to Histiocytosis, Langerhans-Cell
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Proto-Oncogene Proteins B-raf

Share to Signal Transduction

Share to T-Lymphocytes, Regulatory

Source

Identifiers

PMID: 35680836
DOI: 10.19746/j.cnki.issn.1009-2137.2022.03.050

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Progress in the Treatment of Adult Langerhans Cell Histiocytosis --Review].PMID 35680836Read ↗

[Pathophysiology and treatment of adult Langerhans cell histiocytosis].Semantic proximity Read ↗

[Updated AWMF Guideline on the Diagnosis and Treatment of Langerhans cell Histiocytosis in Children and Adolescents].Semantic proximity Read ↗

[Reaserch Advance on Langerhans Cell Histiocytosis Review].Semantic proximity Read ↗

[Langerhans and non-Langerhans histiocytosis].Semantic proximity Read ↗

Langerhans cell histiocytosis in Chinese adults: absence of BRAF mutations and increased FOXP3(+) regulatory T cells.Semantic proximity Read ↗

International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults.Semantic proximity Read ↗

Clinical and prognostic features of Langerhans cell histiocytosis in adults.Semantic proximity Read ↗

Langerhans cell histiocytosis: current advances in molecular pathogenesis.Semantic proximity Read ↗

[Elucidated pathogenesis and therapeutic prospects in Langerhans cell histiocytosis].Semantic proximity Read ↗

Signaling pathways, microenvironment, and targeted treatments in Langerhans cell histiocytosis.Semantic proximity Read ↗

[Clinicopathological analysis of 48 children with Langerhans cell histiocytosis].Semantic proximity Read ↗

[An overview of histiocytosis].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.